Project/Area Number |
18K08146
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 53030:Respiratory medicine-related
|
Research Institution | Oita University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
山末 まり 大分大学, 医学部, 講師 (40555174)
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2023)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2020: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Keywords | 肺線維症 / サーファクタントタンパク質 / オステオポンチン |
Outline of Final Research Achievements |
We investigated the effect of loss of osteopontin function on the spontaneous development of pulmonary fibrosis in SftpcI73T knock-in mice, in which the main osteopontin-producing cells were macrophages and high concentrations of full-length and N-terminal osteopontin were detected in the lung lesion area. We generated SftpcI73T knock-in and Spp1 knock-out mice by crossing SftpcI73T knock-in mice with osteopontin (Spp1) knock-out mice. Loss of function of full-length osteopontin increased inflammatory cell infiltration and activation of cytokines and chemokines during the inflammatory phase. Osteopontin knockout did not improve lung fibrosis.
|
Academic Significance and Societal Importance of the Research Achievements |
今回の研究では,従来の報告と異なり,「オステオポンチンの機能喪失は,肺の炎症を増悪させ,肺線維化を改善しない」ことが明らかになり,本研究成果は,「オステオポンチンを治療ターゲットにするためには,オステオポンチンの機能喪失ではなく,オステオポンチンの機能調節が必要である」という学術的意義を持つ.さらに,本研究成果は,「オステオポンチン機能調節機能を,肺線維症の創薬に発展できる」という社会的意義を持つ.
|